Physician profile
Randy Semma
NPI 1386933125
$30,750.91
in general payments reported to CMS, 2019-2025
31 companies · $19K in 2025
The $19K reported for 2025 was more than what 98% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,750 · 2020: $647 · 2021: $598 · 2022: $2,046 · 2023: $2,088 · 2024: $3,686 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $10K · Food and Beverage: $7,113 · Travel and Lodging: $4,696 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,298 · Education: $1,080 · Consulting Fee: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,217.50 |
| Food and Beverage | $7,113.43 |
| Travel and Lodging | $4,696.27 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,298.00 |
| Education | $1,079.92 |
| Consulting Fee | $305.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $17,366.74 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Arthrex, INC. | $2,190.41 | 2019-2020 | |
| Orthofix Medical, INC. | $1,865.35 | 2023-2025 | Truelok, Truelok Evo |
| Integra Lifesciences Corporation | $1,564.79 | 2020-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paragon 28, INC. | $1,409.45 | 2020-2022 | |
| Depuy Synthes Sales INC. | $1,153.27 | 2023-2025 | Na, Motoband, Foot Osteotomy Wedge System |
| Pinnacle, INC | $734.75 | 2019-2022 | |
| Smith+Nephew, INC. | $655.71 | 2020-2025 | Stravix, Grafix, Oasis |
| Organogenesis INC. | $598.89 | 2021-2025 | Puraply Wound Matrix, Apligraf, Puraply |
| Stryker Corporation | $416.88 | 2020-2025 | Clottriever Bold Catheter, N/A, Augment Injectable |
| Mimedx Group, INC. | $381.35 | 2024-2025 | |
| Abbvie INC. | $350.93 | 2019-2025 | |
| Inari Medical, INC. | $314.25 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $249.49 | 2023-2025 | Venaseal |
| Aroa Biosurgery Incorporated | $212.66 | 2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $194.12 | 2024-2025 | |
| Acera Surgical, INC. | $150.57 | 2024 | Restrata Wound Matrix |
| Penumbra, INC. | $125.18 | 2023 | Indigo System |
| Ani Pharmaceuticals, INC. | $125.00 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $118.44 | 2021 | |
| Amgen INC. | $110.76 | 2024 | Krystexxa |
| Medela LLC | $100.04 | 2020 | |
| Solventum Corporation | $95.58 | 2025 | V.A.C. Dermatac, Activ.A.C., Promogran Prisma |
| Davol INC. | $89.48 | 2024 | Arista Ah Flexitip |
| Hydrofera LLC | $57.57 | 2023 | Hydrofera Blue |
| Convatec INC. | $33.92 | 2023 | |
| Averitas Pharma INC. | $29.74 | 2023 | Qutenza |
| Wright Medical Technology, INC. | $14.81 | 2019 | |
| Hartmann USA, INC. | $14.47 | 2021 | |
| Axogen | $14.39 | 2021 | |
| Grt US Holding, INC. | $11.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Semma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.